Trademark: 88837713
Word
JULIPTA
Status
Dead
Status Code
606
Status Date
Monday, September 12, 2022
Serial Number
88837713
Mark Type
4000
Filing Date
Tuesday, March 17, 2020
Published for Opposition
Tuesday, June 16, 2020
Abandoned Date
Monday, September 12, 2022

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Sep 12, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 12, 2022
Abandonment - No Use Statement Filed
Feb 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2022
Sou Extension 3 Granted
Feb 3, 2022
Sou Extension 3 Filed
Feb 3, 2022
Teas Extension Received
Aug 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2021
Sou Extension 2 Granted
Aug 9, 2021
Sou Extension 2 Filed
Aug 9, 2021
Teas Extension Received
Feb 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2021
Sou Extension 1 Granted
Feb 8, 2021
Sou Extension 1 Filed
Feb 8, 2021
Teas Extension Received
Aug 11, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 16, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 16, 2020
Published For Opposition
Jun 3, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 3, 2020
Teas Change Of Correspondence Received
Jun 3, 2020
Teas Change Of Owner Address Received
May 27, 2020
Notification Of Notice Of Publication E-Mailed
May 11, 2020
Assigned To Lie
May 2, 2020
Approved For Pub - Principal Register
Apr 21, 2020
Notification Of Non-Final Action E-Mailed
Apr 21, 2020
Non-Final Action E-Mailed
Apr 21, 2020
Non-Final Action Written
Apr 21, 2020
Assigned To Examiner
Mar 21, 2020
New Application Office Supplied Data Entered In Tram
Mar 20, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24